History of the Genomadix CUBE

Genomadix’s technology has grown and changed to fit industry needs since the company’s inception in 2005. Below is a timeline of our accomplishments and milestones that has led to the creation of the Genomadix CUBE as you know it today.

The Genomadix CUBE Build On Over 15 Years Of Cutting Edge R&D

2020

Submitted the COVID-19 System to Health Canada for assessment to provide authorization to sell in Canada.

European Commercialization Launch: five distributors signed in Europe.

the EU flag

The TAILOR-PCI study is published in JAMA, featuring the use of the Genomadix RX CYP2C19 Test.

Hand with glove holding catridge

2018

Genomadix CUBE receives CE IVD Certification.

CE certification icon

2016

Genomadix CUBE is announced.

The Genomadix Legionella Test launched.

the spartan cube legionella test

2014

Canada and Korea approve the Genomadix RX CYP2C19 Test.

Canada & Korea Flag

2013

Genomadix RX receives FDA clearance.

2012

Genomadix RX Technology used in POPular Genetics, 2,488 patient trial.

Popular Genetics

2010

Genomadix RX receives CE Marking for Europe, Africa, Asia.

CE

2010

Genomadix RX CYP2C19 test introduced.

Spartan RX analyzer

2006

Genomadix DX DNA Analyzer launched.

Spartan DX Analyzer

2005

Genomadix was founded.